WO2020253512A1 - Treatment instrument and application thereof in regulating hypertension, hyperlipidaemia, and hyperglycaemia in human body - Google Patents

Treatment instrument and application thereof in regulating hypertension, hyperlipidaemia, and hyperglycaemia in human body Download PDF

Info

Publication number
WO2020253512A1
WO2020253512A1 PCT/CN2020/093695 CN2020093695W WO2020253512A1 WO 2020253512 A1 WO2020253512 A1 WO 2020253512A1 CN 2020093695 W CN2020093695 W CN 2020093695W WO 2020253512 A1 WO2020253512 A1 WO 2020253512A1
Authority
WO
WIPO (PCT)
Prior art keywords
wavelength
application
led light
therapeutic apparatus
emitting module
Prior art date
Application number
PCT/CN2020/093695
Other languages
French (fr)
Chinese (zh)
Inventor
陈木程
Original Assignee
深圳晶多宝科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳晶多宝科技有限公司 filed Critical 深圳晶多宝科技有限公司
Publication of WO2020253512A1 publication Critical patent/WO2020253512A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0635Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0636Irradiating the whole body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0651Diodes
    • A61N2005/0652Arrays of diodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light

Definitions

  • This application belongs to the field of medical and health care equipment, and in particular relates to a therapeutic instrument and its application in regulating human body three high schools.
  • hyperlipidemia Three highs are the general term for hyperlipidemia, hypertension, and hyperglycemia.
  • Clinically, insulin resistance, hyperinsulinemia, and impaired glucose tolerance in hyperglycemia are collectively referred to as hypertriglyceridemia and hypertension in hyperlipidemia. It is called “Syndrome X", which is now the metabolic syndrome generally referred to in the medical field.
  • the treatment method for the three highs is mainly controlled by drugs combined with diet therapy. Patients with the three highs need to take medication regularly and cooperate with certain diet control to achieve the purpose of treating the three highs, which brings great inconvenience to the patients. .
  • the present application provides a therapeutic apparatus and its application in regulating the three-highs of the human body to solve the technical defects in the prior art that the treatment methods for the three-highs bring great inconvenience to patients.
  • the application provides a therapeutic apparatus, which includes: an LED light-emitting module with a wavelength of 650 nm to 665 nm.
  • the LED lamp bead density of the LED light-emitting module is 1 to 5 pcs/cm 2 .
  • the therapeutic apparatus further includes: an LED light emitting module with a wavelength of 750 nm to 780 nm.
  • the ratio of the number of LED light-emitting modules with a wavelength of 650-665 nm to that of LED light-emitting modules with a wavelength of 750-780 nm is (6-8): (2-4).
  • the therapeutic apparatus further includes: an LED light emitting module with a wavelength of 800 to 820 nm.
  • the ratio of the number of LED light-emitting modules with a wavelength of 650 to 665 nm, LED light-emitting modules with a wavelength of 750-780 nm and LED light-emitting modules with a wavelength of 800 to 820 nm is (4-6): (2 ⁇ 3): (2 ⁇ 3).
  • the single working time of the therapeutic apparatus is 10-60 minutes.
  • the single physical treatment area of the treatment instrument is 100 to 20000 cm 2 .
  • the application also provides an application of the therapeutic device including any one of the above in regulating hypertension, hyperlipidemia and hyperglycemia in humans.
  • the irradiation position of the treatment device is any one or more of the back, chest, abdomen, arms and legs.
  • the present application provides a therapeutic apparatus, which includes an LED light-emitting module with a wavelength of 650 nm to 665 nm.
  • the application also provides an application of the above-mentioned therapeutic instrument in regulating hypertension, hyperlipidemia and hyperglycemia in humans.
  • the photothermal reaction and/or photochemical reaction generated can activate various metabolic enzymes in the body, promote the body's metabolism, and accelerate the elimination of free radicals in the body, thereby Reduce cholesterol content in the body, improve blood vessel elasticity, regulate blood pressure, and adjust blood lipids, blood pressure and blood sugar to within normal limits.
  • the therapeutic apparatus provided by the present application and its application in regulating the three highs of the human body solve the technical defects in the prior art that the treatment methods for the three highs bring great inconvenience to patients.
  • Figure 1 is a schematic diagram of one of the physical therapy scenarios of the therapeutic apparatus provided by this application.
  • therapeutic apparatus 1 and physical therapist 2.
  • the present application provides a therapeutic apparatus and its application in regulating the three highs of the human body, which is used to solve the technical defects in the prior art that the treatment methods for the three highs bring great inconvenience to patients.
  • This application provides a therapeutic apparatus including: an LED light emitting module with a wavelength of 650 nm to 665 nm.
  • the therapeutic apparatus provided by the present application and its application in regulating the three highs of the human body solve the technical defects in the prior art that the treatment methods for the three highs bring great inconvenience to patients.
  • an LED light-emitting module with a wavelength of 650 to 665 is selected. After directly irradiating the physiotherapist, a photothermal effect and photochemical reaction can be generated, thereby activating a variety of metabolic enzymes in the physiotherapist to ablate and decompose the blood A variety of fats, while reducing blood lipids, can also increase blood oxygen levels.
  • the blood oxygen content in the body of the physiotherapist increases, it can promote the body's metabolism, accelerate the elimination of free radicals in the body, and promote the secretion of insulin by the pancreas, thereby reducing the body's cholesterol and blood sugar levels. At the same time, it can also improve the elasticity of blood vessels and reduce The purpose of regulating blood pressure is to effectively regulate blood lipids, blood pressure and blood sugar within the normal range.
  • the LED is illuminated
  • the LED lamp bead density of the module is 1 ⁇ 5 pcs/cm 2 .
  • the treatment device provided by the embodiment of the application further includes: wavelength It is a 750-780nm LED light-emitting module.
  • the treatment device provided by the embodiment of the application further includes: wavelength LED light-emitting module with 800 ⁇ 820nm.
  • the LED light-emitting module with a wavelength of 800 ⁇ 820nm not only produces a certain supplement and synergy, but also has an analgesic effect, effectively reducing some pain problems of physiotherapists.
  • the LED light-emitting module with a wavelength of 650-665nm plays the main role of adjusting the three heights, while the LED light-emitting module with a wavelength of 750-780nm mainly plays a synergistic supplementary effect. Therefore, the treatment device Good physical therapy effect and supplementary and synergistic effects of different light-emitting modules.
  • the ratio of the number of LED light-emitting modules with a wavelength of 650 to 665 nm to that of LED light-emitting modules with a wavelength of 750 to 780 nm is ( 6 ⁇ 8): (2 ⁇ 4).
  • the ratio of the number of LED light-emitting modules with a wavelength of 650 to 665 nm, LED light-emitting modules with a wavelength of 750 to 780 nm and LED light-emitting modules with a wavelength of 800 to 820 nm is (4 ⁇ 6):(2 ⁇ 3):(2 ⁇ 3).
  • the single working time of the treatment device It is 10 ⁇ 60min.
  • the single treatment area of the provided treatment instrument is 100 ⁇ 20000cm 2 .
  • the irradiation position of a therapeutic device is: back , Chest, abdomen, arms and legs any one or more parts.
  • Example 1 Subject, male, 65 years old. Before the test, his blood pressure was about 165 (mmHg) for systolic blood pressure and about 110 (mmHg) for diastolic blood pressure; using the therapeutic apparatus prepared by the technical scheme provided by this application to irradiate 15 ⁇ After 20 days, the blood pressure was tested again. The results showed that the systolic blood pressure returned to about 138 (mmHg) and the diastolic blood pressure was about 90 (mmHg).
  • Example 2 Subject, female, 60 years old, her fasting blood glucose was about 8.9mmol/l before the test; using the treatment device made by the technical scheme provided in this application for 20 to 30 days, her fasting blood glucose dropped to 6.0mmol /l around.
  • Example 3 Subject, female, 55 years old, before the test, the result of the test of serum total cholesterol is: 6.8mmoi/l, serum triglyceride: 2.5mmoi/l, high-density lipoprotein cholesterol is 2.4mmoi/l About l, the low-density lipoprotein cholesterol is about 4.1mmoi/l; use the therapeutic apparatus made by the technical solution provided by this application to irradiate for 15-20 days, and then test the total serum cholesterol. The result is: 4.9mmoi/l, about, serum glycerin Three lipids: about 1.6mmoi/l, high-density lipoprotein cholesterol is about 1.8mmoi/l, low-density lipoprotein cholesterol is about 2.7mmoi/l.
  • the therapeutic apparatus also provided in this application can be applied to regulate hypertension, hyperlipidemia and hyperglycemia in the human body.
  • the present application provides a therapeutic apparatus, which includes an LED light-emitting module with a wavelength of 650 nm to 665 nm.
  • the application also provides an application of the above-mentioned therapeutic apparatus in regulating hypertension, hyperlipidemia and hyperglycemia in humans.
  • the photothermal reaction and/or photochemical reaction generated can activate various metabolic enzymes in the body, promote the body's metabolism, and accelerate the elimination of free radicals in the body, thereby Reduce cholesterol content in the body, improve blood vessel elasticity, regulate blood pressure, and adjust blood lipids, blood pressure and blood sugar to within normal limits.
  • the therapeutic apparatus provided by the present application and its application in regulating the three highs of the human body solve the technical defects in the prior art that the treatment methods for the three highs bring great inconvenience to patients.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A treatment instrument, relating to the field of medical and healthcare devices. The treatment instrument comprises: an LED light-emitting module having a wavelength of 650-665 nm. Also provided is an application of the treatment instrument in regulating hypertension, hyperlipidaemia, and hyperglycaemia in the human body. When the human body is irradiated with light of a specific wavelength, the produced photothermal reaction and/or photochemical reaction activates various metabolic enzymes in the body, promotes the metabolism of the organism, and accelerates the elimination of free radicals in the body, thereby reducing the cholesterol content in the body, improving blood vessel elasticity, and regulating blood pressure, adjusting blood lipids, blood pressure, and blood sugar to within normal ranges. The technical defect in the prior art of treatment methods for hypertension, hyperlipidaemia, and hyperglycaemia causing great inconvenience to the patient is thereby solved.

Description

一种治疗仪及其在调节人体三高中的应用A therapeutic instrument and its application in regulating human body three high schools 技术领域Technical field
本申请属于医疗保健器械领域,尤其涉及一种治疗仪及其在调节人体三高中的应用。This application belongs to the field of medical and health care equipment, and in particular relates to a therapeutic instrument and its application in regulating human body three high schools.
背景技术Background technique
三高是高血脂、高血压、高血糖的总称,临床上,将高血糖中的胰岛素抵抗、高胰岛素血症、糖耐量异常,高血脂中的高甘油三脂血症和高血压统一合称为“X综合征”,即现在医学界一般说的代谢综合征。Three highs are the general term for hyperlipidemia, hypertension, and hyperglycemia. Clinically, insulin resistance, hyperinsulinemia, and impaired glucose tolerance in hyperglycemia are collectively referred to as hypertriglyceridemia and hypertension in hyperlipidemia. It is called "Syndrome X", which is now the metabolic syndrome generally referred to in the medical field.
技术问题technical problem
现有技术中,针对于三高的治疗方法主要是通过药物合并食疗进行控制,三高患者需要定时服药,配合一定的饮食控制,来达到治疗三高的目的,给患者带来很大的不便。In the prior art, the treatment method for the three highs is mainly controlled by drugs combined with diet therapy. Patients with the three highs need to take medication regularly and cooperate with certain diet control to achieve the purpose of treating the three highs, which brings great inconvenience to the patients. .
因此,研发出一种治疗仪及其在调节人体三高中的应用,用于解决现有技术中,针对于三高的治疗方法给患者带来很大不便的技术缺陷,成为了本领域技术人员亟待解决的问题。Therefore, a therapeutic apparatus and its application in regulating the three highs of the human body have been developed to solve the technical defects in the prior art that the treatment methods for the three highs bring great inconvenience to patients, and become a person skilled in the art Problems to be solved.
技术解决方案Technical solutions
有鉴于此,本申请提供了一种治疗仪及其在调节人体三高中的应用,用于解决现有技术中,针对于三高的治疗方法给患者带来很大不便的技术缺陷。In view of this, the present application provides a therapeutic apparatus and its application in regulating the three-highs of the human body to solve the technical defects in the prior art that the treatment methods for the three-highs bring great inconvenience to patients.
本申请提供了一种治疗仪,所述治疗仪包括:波长为650~665nm的LED发光模块。The application provides a therapeutic apparatus, which includes: an LED light-emitting module with a wavelength of 650 nm to 665 nm.
优选地,所述LED发光模块的LED灯珠密度为1~5个/cm 2Preferably, the LED lamp bead density of the LED light-emitting module is 1 to 5 pcs/cm 2 .
优选地,所述治疗仪还包括:波长为750~780nm的LED发光模块。Preferably, the therapeutic apparatus further includes: an LED light emitting module with a wavelength of 750 nm to 780 nm.
优选地,所述治疗仪中,波长为650~665nm的LED发光模块与波长为750~780nm的LED发光模块的数量比为(6~8):(2~4)。Preferably, in the therapeutic apparatus, the ratio of the number of LED light-emitting modules with a wavelength of 650-665 nm to that of LED light-emitting modules with a wavelength of 750-780 nm is (6-8): (2-4).
优选地,所述治疗仪还包括:波长为800~820nm的LED发光模块。Preferably, the therapeutic apparatus further includes: an LED light emitting module with a wavelength of 800 to 820 nm.
优选地,所述治疗仪中,波长为650~665nm的LED发光模块、波长为750~780nm的LED发光模块与波长为800~820nm的LED发光模块的数量比为(4~6):(2~3):(2~3)。Preferably, in the therapeutic apparatus, the ratio of the number of LED light-emitting modules with a wavelength of 650 to 665 nm, LED light-emitting modules with a wavelength of 750-780 nm and LED light-emitting modules with a wavelength of 800 to 820 nm is (4-6): (2 ~3): (2~3).
优选地,所述治疗仪的单次工作时间为10~60min。Preferably, the single working time of the therapeutic apparatus is 10-60 minutes.
优选地,所述治疗仪的单次理疗面积为100~20000cm 2Preferably, the single physical treatment area of the treatment instrument is 100 to 20000 cm 2 .
本申请还提供了一种包括以上任意一项所述的治疗仪在调节人体内高血压、高血脂以及高血糖中的应用。The application also provides an application of the therapeutic device including any one of the above in regulating hypertension, hyperlipidemia and hyperglycemia in humans.
优选地,所述治疗仪的照射部位为:背部、胸部、腹部、手臂以及腿部中的任意一个部位或多个部位。Preferably, the irradiation position of the treatment device is any one or more of the back, chest, abdomen, arms and legs.
有益效果Beneficial effect
综上所述,本申请提供了一种治疗仪,所述治疗仪包括:波长为650~665nm的LED发光模块。本申请还提供了一种上述治疗仪在调节人体内高血压、高血脂以及高血糖中的应用。本申请提供的技术方案中,通过特定波长的光对人体照射时,所产生的光热反应和/或光化学反应,激活体内的多种代谢酶、促进机体新陈代谢、加速体内自由基的清除,从而降低体内胆固醇含量、改善血管弹性、调节血压,将血脂、血压及血糖调节至正常范围内。本申请提供的一种治疗仪及其在调节人体三高中的应用,解决了现有技术中,针对于三高的治疗方法给患者带来很大不便的技术缺陷。In summary, the present application provides a therapeutic apparatus, which includes an LED light-emitting module with a wavelength of 650 nm to 665 nm. The application also provides an application of the above-mentioned therapeutic instrument in regulating hypertension, hyperlipidemia and hyperglycemia in humans. In the technical solution provided by this application, when the human body is irradiated with light of a specific wavelength, the photothermal reaction and/or photochemical reaction generated can activate various metabolic enzymes in the body, promote the body's metabolism, and accelerate the elimination of free radicals in the body, thereby Reduce cholesterol content in the body, improve blood vessel elasticity, regulate blood pressure, and adjust blood lipids, blood pressure and blood sugar to within normal limits. The therapeutic apparatus provided by the present application and its application in regulating the three highs of the human body solve the technical defects in the prior art that the treatment methods for the three highs bring great inconvenience to patients.
附图说明Description of the drawings
为了更清楚地说明本申请实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本申请的实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据提供的附图获得其他的附图。In order to more clearly describe the technical solutions in the embodiments of the present application or the prior art, the following will briefly introduce the drawings that need to be used in the description of the embodiments or the prior art. Obviously, the drawings in the following description are only It is an embodiment of the present application. For those of ordinary skill in the art, other drawings can be obtained according to the provided drawings without creative work.
图1为本申请提供的治疗仪的其中一种理疗场景的示意图;Figure 1 is a schematic diagram of one of the physical therapy scenarios of the therapeutic apparatus provided by this application;
其中,治疗仪1以及理疗者2。Among them, therapeutic apparatus 1 and physical therapist 2.
本发明的实施方式Embodiments of the invention
本申请提供了一种治疗仪及其在调节人体三高中的应用,用于解决现有技术中,针对于三高的治疗方法给患者带来很大不便的技术缺陷。The present application provides a therapeutic apparatus and its application in regulating the three highs of the human body, which is used to solve the technical defects in the prior art that the treatment methods for the three highs bring great inconvenience to patients.
下面将对本申请实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本申请一部分实施例,而不是全部的实施例。基于本申请中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本申请保护的范围。The technical solutions in the embodiments of the present application will be described clearly and completely below. Obviously, the described embodiments are only a part of the embodiments of the present application, rather than all the embodiments. Based on the embodiments in this application, all other embodiments obtained by those of ordinary skill in the art without creative work shall fall within the protection scope of this application.
为了更详细说明本申请,下面结合附图对本申请提供的一种治疗仪及其在调节人体三高中的应用,进行具体地描述。In order to explain this application in more detail, the therapeutic apparatus provided by this application and its application in regulating the three highs of the human body will be described in detail below with reference to the accompanying drawings.
请参阅图1,本申请提供了一种治疗仪,包括:波长为650~665nm的LED发光模块。本申请提供的一种治疗仪及其在调节人体三高中的应用,解决了现有技术中,针对于三高的治疗方法给患者带来很大不便的技术缺陷。Please refer to Fig. 1. This application provides a therapeutic apparatus including: an LED light emitting module with a wavelength of 650 nm to 665 nm. The therapeutic apparatus provided by the present application and its application in regulating the three highs of the human body solve the technical defects in the prior art that the treatment methods for the three highs bring great inconvenience to patients.
本申请提供的技术方案中,选用波长为650~665波段的LED发光模块,直接照射理疗者后,可产生光热效应及光化学反应,从而激活理疗者体内的多种代谢酶,消融分解血液中的多种脂肪,降低血脂的同时,还可以起到提升血氧含量的作用。In the technical solution provided in this application, an LED light-emitting module with a wavelength of 650 to 665 is selected. After directly irradiating the physiotherapist, a photothermal effect and photochemical reaction can be generated, thereby activating a variety of metabolic enzymes in the physiotherapist to ablate and decompose the blood A variety of fats, while reducing blood lipids, can also increase blood oxygen levels.
进一步地,当理疗者体内的血氧含量提升后,可促进机体新陈代谢、加速体内自由基的清除及促进胰腺分泌胰岛素,从而降低体内胆固醇及血糖含量,同时,还可改善血管弹性,起到降低调节血压的目的,有效将血脂、血压及血糖调节至正常范围内。Further, when the blood oxygen content in the body of the physiotherapist increases, it can promote the body's metabolism, accelerate the elimination of free radicals in the body, and promote the secretion of insulin by the pancreas, thereby reducing the body's cholesterol and blood sugar levels. At the same time, it can also improve the elasticity of blood vessels and reduce The purpose of regulating blood pressure is to effectively regulate blood lipids, blood pressure and blood sugar within the normal range.
在实际应用的过程中,兼顾以良好的三高改善效果,及LED发光模块灯泡分布的合理性、低成本及便于日常维护的设计需求,本申请实施例提供的一种治疗仪中,LED发光模块的LED灯珠密度为1~5个/cm 2In the actual application process, taking into account the good three-high improvement effect, the rationality of the bulb distribution of the LED light-emitting module, the low cost, and the design requirements of convenient daily maintenance, in the therapeutic apparatus provided by the embodiment of the application, the LED is illuminated The LED lamp bead density of the module is 1~5 pcs/cm 2 .
进一步地优化技术方案,有效优化治疗仪的理疗效果,对波长为650~665的LED发光模块的理疗效果起到有效的补充、协同作用,本申请实施例提供的一种治疗仪还包括:波长为750~780nm的LED发光模块。Further optimize the technical scheme, effectively optimize the physiotherapy effect of the treatment device, and effectively supplement and synergize the physiotherapy effect of the LED light-emitting module with a wavelength of 650 to 665. The treatment device provided by the embodiment of the application further includes: wavelength It is a 750-780nm LED light-emitting module.
进一步地优化技术方案,有效优化治疗仪的理疗效果,对波长为650~665的LED发光模块的理疗效果起到有效的补充、协同作用,本申请实施例提供的一种治疗仪还包括:波长为800~820nm的LED发光模块。同时,波长为800~820nm的LED发光模块除产生一定的补充、协同作用外,还具有镇痛的效果,有效减轻理疗者的一些疼痛问题。Further optimize the technical scheme, effectively optimize the physiotherapy effect of the treatment device, and effectively supplement and synergize the physiotherapy effect of the LED light-emitting module with a wavelength of 650 to 665. The treatment device provided by the embodiment of the application further includes: wavelength LED light-emitting module with 800~820nm. At the same time, the LED light-emitting module with a wavelength of 800~820nm not only produces a certain supplement and synergy, but also has an analgesic effect, effectively reducing some pain problems of physiotherapists.
在治疗仪工作的过程中,波长为650~665nm的LED发光模块起到了主要的调节三高的作用,而波长为750~780nm的LED发光模块主要起到协同补充作用,因此,兼顾以治疗仪良好的理疗效果及不同发光模块的补充、协同效果,本申请实施例提供的一种治疗仪中,波长为650~665nm的LED发光模块与波长为750~780nm的LED发光模块的数量比为(6~8):(2~4)。In the working process of the treatment device, the LED light-emitting module with a wavelength of 650-665nm plays the main role of adjusting the three heights, while the LED light-emitting module with a wavelength of 750-780nm mainly plays a synergistic supplementary effect. Therefore, the treatment device Good physical therapy effect and supplementary and synergistic effects of different light-emitting modules. In the therapeutic apparatus provided in the embodiment of the application, the ratio of the number of LED light-emitting modules with a wavelength of 650 to 665 nm to that of LED light-emitting modules with a wavelength of 750 to 780 nm is ( 6~8): (2~4).
同理,本申请实施例提供的一种治疗仪中,波长为650~665nm的LED发光模块、波长为750~780nm的LED发光模块与波长为800~820nm的LED发光模块的数量比为(4~6):(2~3):(2~3)。Similarly, in the therapeutic apparatus provided by the embodiment of the present application, the ratio of the number of LED light-emitting modules with a wavelength of 650 to 665 nm, LED light-emitting modules with a wavelength of 750 to 780 nm and LED light-emitting modules with a wavelength of 800 to 820 nm is (4 ~6):(2~3):(2~3).
为达到最优理疗效果,有效调节理疗者三高的问题,同时,兼顾以治疗仪的理疗效率及理疗者的耐受程度,本申请实施例提供的技术方案中,治疗仪的单次工作时间为10~60min。In order to achieve the optimal physiotherapy effect, effectively adjust the three high problems of the physiotherapist, and at the same time, take into account the physiotherapy efficiency of the treatment device and the tolerance of the physiotherapist, in the technical solution provided in the embodiments of this application, the single working time of the treatment device It is 10~60min.
由于不同的理疗者,其三高问题的严重程度均不相同,且不同理疗者对于治疗仪的敏感程度也不相同,为提高治疗仪的通用性并兼顾以治疗仪良好的工作效率,本申请提供的治疗仪的单次理疗面积为100~20000cm 2Since different physiotherapists have different severity of the three high problems, and different physiotherapists have different sensitivity to the treatment device, in order to improve the versatility of the treatment device and take into account the good work efficiency of the treatment device, this application The single treatment area of the provided treatment instrument is 100~20000cm 2 .
为实现治疗仪良好的理疗效果,针对于对照射比较敏感,且照射后能有效调节三高的部分,兼顾以理疗的便捷性,本申请实施例提供的一种治疗仪的照射部位为:背部、胸部、腹部、手臂以及腿部中的任意一个部位或多个部位。In order to achieve a good physiotherapy effect of the therapeutic device, the part that is more sensitive to irradiation and can effectively adjust the three heights after irradiation, taking into account the convenience of physiotherapy, the irradiation position of a therapeutic device provided by the embodiment of the application is: back , Chest, abdomen, arms and legs any one or more parts.
使用本申请提供的一种治疗仪,对受试三高志愿者进行理疗后,监测志愿者血脂、血糖和血压变化,结果如下:Using a therapeutic instrument provided in this application, after performing physical therapy on volunteers with three highs, the changes in blood lipids, blood sugar and blood pressure of the volunteers were monitored, and the results were as follows:
例1:受试者,男,65岁,受试前其血压为:收缩压165(mmHg)左右,舒张压110(mmHg)左右;使用本申请提供的技术方案制得的治疗仪照射15~20天,再测试血压结果,显示收缩压恢复到138(mmHg)左右,舒张压90(mmHg)左右。Example 1: Subject, male, 65 years old. Before the test, his blood pressure was about 165 (mmHg) for systolic blood pressure and about 110 (mmHg) for diastolic blood pressure; using the therapeutic apparatus prepared by the technical scheme provided by this application to irradiate 15~ After 20 days, the blood pressure was tested again. The results showed that the systolic blood pressure returned to about 138 (mmHg) and the diastolic blood pressure was about 90 (mmHg).
例2:受试者,女,60岁,受试前其空腹血糖为8.9mmol/l左右;使用本申请提供的技术方案制得的治疗仪照射20~30天,其空腹血糖降至6.0mmol/l左右。Example 2: Subject, female, 60 years old, her fasting blood glucose was about 8.9mmol/l before the test; using the treatment device made by the technical scheme provided in this application for 20 to 30 days, her fasting blood glucose dropped to 6.0mmol /l around.
例3:受试者,女,55岁,受试前,测试血清总胆固醇结果是:6.8mmoi/l,左右,血清甘油三脂:2.5mmoi/l左右,高密度脂蛋白胆固醇是2.4mmoi/l左右,低密度脂蛋白胆固醇是4.1mmoi/l左右;使用本申请提供的技术方案制得的治疗仪照射15-20天,再测试血清总胆固醇结果是:4.9mmoi/l,左右,血清甘油三脂:1.6mmoi/l左右,高密度脂蛋白胆固醇是1.8mmoi/l左右,低密度脂蛋白胆固醇是2.7mmoi/l左右。Example 3: Subject, female, 55 years old, before the test, the result of the test of serum total cholesterol is: 6.8mmoi/l, serum triglyceride: 2.5mmoi/l, high-density lipoprotein cholesterol is 2.4mmoi/l About l, the low-density lipoprotein cholesterol is about 4.1mmoi/l; use the therapeutic apparatus made by the technical solution provided by this application to irradiate for 15-20 days, and then test the total serum cholesterol. The result is: 4.9mmoi/l, about, serum glycerin Three lipids: about 1.6mmoi/l, high-density lipoprotein cholesterol is about 1.8mmoi/l, low-density lipoprotein cholesterol is about 2.7mmoi/l.
由上可见,本申请还提供了的治疗仪,可应用于调节人体内高血压、高血脂以及高血糖。It can be seen from the above that the therapeutic apparatus also provided in this application can be applied to regulate hypertension, hyperlipidemia and hyperglycemia in the human body.
综上所述,本申请提供了一种治疗仪,所述治疗仪包括:波长为650~665nm的LED发光模块。本申请还提供了一种上述治疗仪在调节人体内高血压、高血脂以及高血糖中的应用。本申请提供的技术方案中,通过特定波长的光对人体照射时,所产生的光热反应和/或光化学反应,激活体内的多种代谢酶、促进机体新陈代谢、加速体内自由基的清除,从而降低体内胆固醇含量、改善血管弹性、调节血压,将血脂、血压及血糖调节至正常范围内。本申请提供的一种治疗仪及其在调节人体三高中的应用,解决了现有技术中,针对于三高的治疗方法给患者带来很大不便的技术缺陷。In summary, the present application provides a therapeutic apparatus, which includes an LED light-emitting module with a wavelength of 650 nm to 665 nm. The application also provides an application of the above-mentioned therapeutic apparatus in regulating hypertension, hyperlipidemia and hyperglycemia in humans. In the technical solution provided by this application, when the human body is irradiated with light of a specific wavelength, the photothermal reaction and/or photochemical reaction generated can activate various metabolic enzymes in the body, promote the body's metabolism, and accelerate the elimination of free radicals in the body, thereby Reduce cholesterol content in the body, improve blood vessel elasticity, regulate blood pressure, and adjust blood lipids, blood pressure and blood sugar to within normal limits. The therapeutic apparatus provided by the present application and its application in regulating the three highs of the human body solve the technical defects in the prior art that the treatment methods for the three highs bring great inconvenience to patients.
以上所述仅是本申请的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本申请原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本申请的保护范围。The above are only the preferred embodiments of this application. It should be pointed out that for those of ordinary skill in the art, without departing from the principle of this application, several improvements and modifications can be made, and these improvements and modifications are also Should be regarded as the scope of protection of this application.

Claims (10)

  1. 一种治疗仪,其特征在于,所述治疗仪包括:波长为650~665nm的LED发光模块。A therapeutic apparatus, characterized in that, the therapeutic apparatus includes: an LED light-emitting module with a wavelength of 650-665 nm.
  2. 根据权利要求1所述的治疗仪,其特征在于,所述LED发光模块的LED灯珠密度为1~5个/cm 2The therapeutic apparatus according to claim 1, wherein the LED lamp bead density of the LED light-emitting module is 1 to 5 pcs/cm 2 .
  3. 根据权利要求1或2所述的治疗仪,其特征在于,所述治疗仪还包括:波长为750~780nm的LED发光模块。The treatment device according to claim 1 or 2, wherein the treatment device further comprises: an LED light-emitting module with a wavelength of 750 nm to 780 nm.
  4. 根据权利要求3所述的治疗仪,其特征在于,所述治疗仪中,波长为650~665nm的LED发光模块与波长为750~780nm的LED发光模块的数量比为(6~8):(2~4)。The therapeutic apparatus according to claim 3, wherein, in the therapeutic apparatus, the ratio of the number of LED light-emitting modules with a wavelength of 650 to 665 nm to that of LED light-emitting modules with a wavelength of 750 to 780 nm is (6-8):( 2~4).
  5. 根据权利要求3所述的治疗仪,其特征在于,所述治疗仪还包括:波长为800~820nm的LED发光模块。The treatment device according to claim 3, wherein the treatment device further comprises: an LED light emitting module with a wavelength of 800-820 nm.
  6. 根据权利要求5所述的治疗仪,其特征在于,所述治疗仪中,波长为650~665nm的LED发光模块、波长为750~780nm的LED发光模块与波长为800~820nm的LED发光模块的数量比为(4~6):(2~3):(2~3)。The therapeutic apparatus according to claim 5, wherein, in the therapeutic apparatus, the LED light-emitting module with a wavelength of 650-665nm, the LED light-emitting module with a wavelength of 750-780nm and the LED light-emitting module with a wavelength of 800-820nm The quantity ratio is (4~6):(2~3):(2~3).
  7. 根据权利要求1所述的治疗仪,其特征在于,所述治疗仪的单次工作时间为10~60min。The treatment device according to claim 1, wherein the single working time of the treatment device is 10-60 minutes.
  8. 根据权利要求1所述的治疗仪,其特征在于,所述治疗仪的单次理疗面积为100~20000cm 2The therapeutic apparatus according to claim 1, wherein the area of a single physical treatment of the therapeutic apparatus is 100 to 20000 cm 2 .
  9. 一种包括权利要求1至8任意一项所述的治疗仪在调节人体内高血压、高血脂以及高血糖中的应用。An application of the therapeutic device according to any one of claims 1 to 8 in regulating hypertension, hyperlipidemia and hyperglycemia in humans.
  10. 根据权利要求9所述的应用,其特征在于,所述治疗仪的照射部位为:背部、胸部、腹部、手臂以及腿部中的任意一个部位或多个部位。The application according to claim 9, wherein the irradiation part of the treatment device is any one or more parts of the back, chest, abdomen, arms and legs.
PCT/CN2020/093695 2019-06-18 2020-06-01 Treatment instrument and application thereof in regulating hypertension, hyperlipidaemia, and hyperglycaemia in human body WO2020253512A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910535466.4A CN110237434A (en) 2019-06-18 2019-06-18 A kind of physiotherapy equipment and its application in adjusting three senior middle school of human body
CN201910535466.4 2019-06-18

Publications (1)

Publication Number Publication Date
WO2020253512A1 true WO2020253512A1 (en) 2020-12-24

Family

ID=67888297

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/093695 WO2020253512A1 (en) 2019-06-18 2020-06-01 Treatment instrument and application thereof in regulating hypertension, hyperlipidaemia, and hyperglycaemia in human body

Country Status (2)

Country Link
CN (1) CN110237434A (en)
WO (1) WO2020253512A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110237434A (en) * 2019-06-18 2019-09-17 深圳晶多宝科技有限公司 A kind of physiotherapy equipment and its application in adjusting three senior middle school of human body
CN113975656B (en) * 2021-12-13 2023-10-13 固安翌光科技有限公司 Phototherapy device for treating neonatal jaundice

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101084041A (en) * 2004-09-13 2007-12-05 照片诊断设备(Pdd)有限公司 Apparatus for photodynamic therapy
CN101678209A (en) * 2007-05-31 2010-03-24 皇家飞利浦电子股份有限公司 Method and system for providing illumination and physiological stimuli
CN101990449A (en) * 2008-04-10 2011-03-23 皇家飞利浦电子股份有限公司 Body illumination system using blue light
CN203060602U (en) * 2013-01-28 2013-07-17 王玲玲 Portable infrared radiation therapeutic apparatus
WO2018152255A1 (en) * 2017-02-15 2018-08-23 The Regents Of The University Of California Improved light therapy system and methods of use
WO2019023800A1 (en) * 2017-08-02 2019-02-07 Suntracker Technologies Ltd. Transitional lighting for entraining biological rhythms
CN208582419U (en) * 2018-04-16 2019-03-08 中南光子科技宿迁有限公司 A kind of photon diabetes therapeutic instrument for monitoring blood glucose and treating postprandial hyperglycemia
CN110237434A (en) * 2019-06-18 2019-09-17 深圳晶多宝科技有限公司 A kind of physiotherapy equipment and its application in adjusting three senior middle school of human body

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101559258A (en) * 2009-05-08 2009-10-21 天津滨海华医光电技术有限公司 Multi-wavelength output semiconductor laser treatment instrument
US8551147B2 (en) * 2009-06-01 2013-10-08 Hangzhou Dalishen Medical Device Ltd. Hypertension therapy instrument and method for treating hypertension
CN101869740B (en) * 2010-06-23 2012-02-01 上海理工大学 Hood device for treating brain central nervous system diseases
CN101934116B (en) * 2010-08-20 2013-04-17 上海世鹏实验室科技发展有限公司 Phototherapy device
CN103505816A (en) * 2012-06-25 2014-01-15 重庆信涵光电科技有限公司 Information-content broad-width optical band filter
CN202666198U (en) * 2012-07-09 2013-01-16 杨顺仕 Micro-tower head therapeutic instrument
CN203539893U (en) * 2013-09-24 2014-04-16 深圳市开颜医疗器械有限公司 Phototherapy health-care pad and phototherapy health-care instrument
CN108853738A (en) * 2017-05-11 2018-11-23 南华大学 Wrist portion light protection device

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101084041A (en) * 2004-09-13 2007-12-05 照片诊断设备(Pdd)有限公司 Apparatus for photodynamic therapy
CN101678209A (en) * 2007-05-31 2010-03-24 皇家飞利浦电子股份有限公司 Method and system for providing illumination and physiological stimuli
CN101990449A (en) * 2008-04-10 2011-03-23 皇家飞利浦电子股份有限公司 Body illumination system using blue light
CN203060602U (en) * 2013-01-28 2013-07-17 王玲玲 Portable infrared radiation therapeutic apparatus
WO2018152255A1 (en) * 2017-02-15 2018-08-23 The Regents Of The University Of California Improved light therapy system and methods of use
WO2019023800A1 (en) * 2017-08-02 2019-02-07 Suntracker Technologies Ltd. Transitional lighting for entraining biological rhythms
CN208582419U (en) * 2018-04-16 2019-03-08 中南光子科技宿迁有限公司 A kind of photon diabetes therapeutic instrument for monitoring blood glucose and treating postprandial hyperglycemia
CN110237434A (en) * 2019-06-18 2019-09-17 深圳晶多宝科技有限公司 A kind of physiotherapy equipment and its application in adjusting three senior middle school of human body

Also Published As

Publication number Publication date
CN110237434A (en) 2019-09-17

Similar Documents

Publication Publication Date Title
WO2020253512A1 (en) Treatment instrument and application thereof in regulating hypertension, hyperlipidaemia, and hyperglycaemia in human body
WO2009039644A1 (en) Adipose resolve apparatus for low-power laser
CN105919780A (en) Acral blood circulation disorder treatment apparatus
CN110141750A (en) A kind of multipurpose wide spectrum therapeutic equipment
CN211068798U (en) Coupled laser acupuncture point therapeutic apparatus
Roche et al. Low-level laser therapy for reducing the hip, waist, and upper abdomen circumference of individuals with obesity
Sahni et al. Recent advances in hyperbaric oxygen therapy
JP3121738U (en) Device for stimulating acupuncture points on the face
Brockow et al. A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis
US20130172967A1 (en) Heat Patch for Cardiovascular Diseases
Hu et al. Acupuncture for disorders of consciousness-A case series and review
CN213312954U (en) Non-invasive light quantum blood-activating acupuncture instrument
Bennett et al. Treatment of chronic craniofacial pain with Mphi laser and orthotic
Salama et al. Effect of acupressure on post natal depression
SAHIER et al. Effect of monochromatic infrared energy light versus laser therapy in diabetic peripheral neuropathy
Huang Critical review of massage therapy employed for newborns
Jensen et al. Dental implant treatment in irradiated oral cancer patients. Clinical routines in Norway and a review of the literature
CN202020634U (en) Vertebral column treatment couch
CN203123348U (en) Semiconductor narrow-spectrum therapeutic apparatus for ache diseases in one's neck, shoulder, waist or leg
CN211273205U (en) Multi-beam external irradiation device for preventing and controlling respiratory infectious diseases
RU2297822C2 (en) Method for strengthening frequently falling ill children health
CN209490388U (en) A kind of ear nose larynx therapeutic device
CN107519581A (en) A kind of light quantum for cancer early prevention and treatment nurses one's health instrument
Septriana et al. Acupuncture and Self Acupressure Treatment of Hemifacial Spasm: A Case Report
Fornaini et al. Case Report “At-Home” Photobiomodulation: A New Approach for Bell’s Palsy Treatment

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20827435

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20827435

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 25/05/2022)